Healthcare - Biotechnology - NASDAQ - US
$ 18.31
-5.86 %
$ 13.5 B
Market Cap
-79.61
P/E
Price Target
Average
47.46%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
--69.02%
Net Income
Estimate
23.54%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Summit Therapeutics Inc.
Wall Street analysts predict an average 1-year price target for SMMT of $27 , with forecasts ranging from a low of $8 to a high of $45 .
SMMT Lowest Price Target
Wall Street Target
8 USD
-56.31%
SMMT Average Price Target
Wall Street Target
27 USD
47.46%
SMMT Highest Price Target
Wall Street Target
45 USD
145.77%
REVENUE FORECAST
Revenue Forecast Chart SMMT
EBIT FORECAST
EBIT Forecast Chart SMMT
NET INCOME FORECAST
Net Income Chart SMMT